Cargando…

Theranostics: radionuclide imaging and therapy in neuroendocrine tumours

Detalles Bibliográficos
Autores principales:	Drake, Brent, Grüning, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601830/ http://dx.doi.org/10.1186/1470-7330-15-S1-O16

Ejemplares similares

Role of molecular imaging in the detection of neuroendocrine tumour
por: Wild, Damian
Publicado: (2014)

Imaging neuroendocrine tumours of the pancreas: role of CT and MRI
por: Sahdev, Anju
Publicado: (2014)

Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach
por: Gordon, S., et al.
Publicado: (2023)

Microbubbles: from cancer detection to theranostics
por: Cosgrove, David
Publicado: (2015)

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours
por: Lim, Lisi Elizabeth, et al.
Publicado: (2020)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
por: Elston, Marianne S., et al.
Publicado: (2021)

Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018)

Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors
por: Yordanova, Anna, et al.
Publicado: (2020)

Imaging tumour response - challenges
por: Rasmussen, Finn
Publicado: (2015)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
por: da Silva, Tiago Nunes, et al.
Publicado: (2018)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Current knowledge of scoliosis in physical therapy students trained in the United States
por: Drake, Shawn, et al.
Publicado: (2014)

Pediatric tumours: liver tumours
por: Towbin, Alexander J
Publicado: (2014)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry
por: Marquis, H., et al.
Publicado: (2021)

Pediatric tumours: pseudotumour or a tumour?
por: Huisman, Thierry AGM
Publicado: (2014)

Optimising structural imaging of neuroendocrine tumours in the molecular imaging age
por: Parameswaran, Bimal Kumar, et al.
Publicado: (2014)

Regulation of metabolism by a neuroendocrine FGF signaling pathway
por: Mangelsdorf, David J, et al.
Publicado: (2014)

Orbital tumours
por: Chong, Vincent
Publicado: (2015)

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
por: Sowa-Staszczak, Anna, et al.
Publicado: (2011)

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Zaknun, John J., et al.
Publicado: (2013)

Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review
por: Huizing, Daphne Merel Valerie, et al.
Publicado: (2018)

Radiation precautions for inpatient and outpatient (177)Lu-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours
por: Levart, D., et al.
Publicado: (2019)

Neuroendocrine tumor theranostics
por: Ichikawa, Yasushi, et al.
Publicado: (2022)

Radial simultaneous multi slice imaging for rapid cardiac imaging
por: Adluru, Ganesh, et al.
Publicado: (2016)

Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?
por: Thibault, F, et al.
Publicado: (2008)

Added-value of molecular imaging in myocardial metastasis of an ileal neuroendocrine tumour treated with peptide receptor radionuclide therapy: a case report
por: Mallón Araujo, María Del Carmen, et al.
Publicado: (2021)

The pathology of inherited breast tumours
por: Stratton, M
Publicado: (2000)

Cavitation detection for brain imaging and therapy
por: O’Reilly, Meaghan, et al.
Publicado: (2015)

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Bodei, L., et al.
Publicado: (2013)

Novel roles for integrins in tumour angiogenesis
por: Germain, M, et al.
Publicado: (2006)

Terbium Radionuclides for Theranostics Applications: A Focus On MEDICIS-PROMED
por: Formento Cavaiera, R, et al.
Publicado: (2020)

Off-resonance insensitive LGE MRI for imaging ventricular scar without image artifacts induced by cardiac devices
por: Ranjan, Ravi, et al.
Publicado: (2014)

Cytomics of the tumour microenvironment: therapeutic targeting (keynote lecture)
por: Smith, Paul
Publicado: (2015)

Self-gated cardiac magnetic resonance perfusion imaging compared with X-ray angiography: a pilot study
por: Harrison, Alexis, et al.
Publicado: (2012)

The use of CO2 laser in tumour resection of the oropharyngeal region
por: Jerjes, Waseem, et al.
Publicado: (2010)

Assessment of tumour resection margins using optical coherence tomography
por: Hamdoon, Zaid, et al.
Publicado: (2010)

Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
por: Coleman, RE
Publicado: (2009)

T2-weighted MRI pulse sequences for imaging post-infarct edema in mice: comparison of spin echo and T2 preparation approaches
por: Beyers, Ronald J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ragttlrn19ogbv5ahru18innf3